ERY-TAB

Product NDC: 68151-1170
11-digit product format: 681511170
Labeler code: 68151
Product ID: 68151-1170_8eb5a5b5-ec11-4db7-b4ff-3f1028e0e442
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: Carilion Materials Management
Application: ANDA062298
Marketing category: ANDA
Marketing start: 2011-04-18
Marketing end: 0000-00-00
Substance: ERYTHROMYCIN
Active strength: 250 mg/1
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68151-1170		I	Inactivated by FDA		2026-08-03
excluded package	package	68151-1170	68151-1170-1	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68151-1170-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68151-1170-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68151-1170-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68151-1170-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68151-1170-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68151-1170-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68151-1170-1	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68151-1170-1	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68151-1170-1	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68151-1170-1	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68151-1170-1	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68151-1170-1	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68151-1170-1	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68151-1170-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68151-1170-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68151-1170-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68151-1170-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68151-1170-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68151-1170-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68151-1170-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68151-1170-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68151-1170-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062298-001	ERY-TAB	ERYTHROMYCIN	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982
A062298-002	ERY-TAB	ERYTHROMYCIN	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982
A062298-003	ERY-TAB	ERYTHROMYCIN	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A062298-001	AB
A062298-002	AB
A062298-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-002	ERY-TAB	500MG	TABLET, DELAYED RELEASE / ORAL	AB	RS, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-003	ERY-TAB	333MG	TABLET, DELAYED RELEASE / ORAL	AB		1982-03-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062298-001	ERY-TAB	250MG	TABLET, DELAYED RELEASE / ORAL	AB	Approved before 1982		`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062298-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062298-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062298-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062298-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062298-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062298-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062298-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062298-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062298-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062298-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062298-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062298-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062298-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062298-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062298-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062298-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062298-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062298-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062298-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062298-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68151-1170-1	2020-01-31	C162847	48780-1	9d75b9d1-22ad-f424-e053-dadaa90a57ce	ERY-TAB (ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP) ENTERIC-COATED ®

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68151-1170-1	ERY-TAB	1 in 1 PACKAGE	TABLET, DELAYED RELEASE	1		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Erythromycin	ACTIVE INGREDIENT	63937KV33D	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
Erythromycin	ACTIVE MOIETY	63937KV33D	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
DIACETYLATED MONOGLYCERIDES	INACTIVE INGREDIENT	5Z17386USF	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)	INACTIVE INGREDIENT	87Y6436BKR	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
SORBITAN MONOOLEATE	INACTIVE INGREDIENT	06XEA2VD56	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68151-1170	ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]	2	Legacy NDC, 1 package rows	20140707_3cb1944b-1090-4fcc-a734-70ba00d2144c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Erythromycin	ERYTHROMYCIN	Wilshire Pharmaceuticals	e9b5abbb-2952-44ce-8cbb-415d9be23df4	2024-12-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062298 application number: ANDA062298
ERY-TAB	ERYTHROMYCIN	Arbor Pharmaceuticals, Inc.	fda44eb6-7901-4b80-ba0b-216f6cacf3fd	2018-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062298 application number: ANDA062298

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
63937KV33D	ERYTHROMYCIN	114-07-8	ERYTHROMYCIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
206075	ERY-TAB 250 MG Delayed Release Oral Tablet	PSN	3cb1944b-1090-4fcc-a734-70ba00d2144c	2
310155	erythromycin 250 MG Delayed Release Oral Tablet	PSN	3cb1944b-1090-4fcc-a734-70ba00d2144c	2
206075	erythromycin 250 MG Delayed Release Oral Tablet [Ery-Tab]	SBD	3cb1944b-1090-4fcc-a734-70ba00d2144c	2
310155	erythromycin 250 MG Delayed Release Oral Tablet	SCD	3cb1944b-1090-4fcc-a734-70ba00d2144c	2
206075	Ery-Tab 250 MG Delayed Release Oral Tablet	SY	3cb1944b-1090-4fcc-a734-70ba00d2144c	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68151-1170-1	68151117001	1 in 1 PACKAGE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ERY-TAB (ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP) ENTERIC-COATED ®	Carilion Materials Management	2014-05-01	HUMAN PRESCRIPTION DRUG LABEL	2